SIM-0518

N/A

Report date: 2026/04/30 20:00:20
NME

Base Information

Drug NameSIM-0518
Drug Alias NameSIM0518SIM-0518
ClassificationOther
Mechanisms of ActionAnaplastic lymphoma kinase inhibitors
TargetsAnaplastic lymphoma kinase
Therapy Area/IndicationsSolid tumoursCarcinoma, Non-Small-Cell Lung
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryMainland China
CombinationsNo
Global Highest StatusPreclinical
Highest Status in ChinaPreclinical
Originator CompaniesSimcere Pharmaceutical Group Ltd
China Registration ClassN/A

Develop Information

Active CompaniesSimcere Pharmaceutical Group Ltd
Inactive CompaniesN/A
Active IndicationsSolid tumoursCarcinoma, Non-Small-Cell Lung
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A